AI vs. cancer: Mount Sinai scientist says breakthrough tech has 'drastic impact' on diagnosis, treatment

Thomas Fuchs, the Dean of Artificial Intelligence and Human Health at Mount Sinai in NYC, said AI will be needed to retain the standard of care in the U.S. Artificial intelligence (AI) is helping physicians to diagnose cancer more accurately at much faster rates and at a lower cost than previously possible, according to a scientist working in computational pathology. Dr. Thomas J. Fuchs, the Dean of Artificial Intelligence and Human Health at Mount Sinai in New York City, also works as the chief scientific officer at Paige AI, a company using AI to detect and treat cancer. The latest study from the company tasked 16 pathologists with the review of 610 whole-slide images prepared at multiple institutions globally. They reviewed the slides once without assistance, and then again with assistance from the Pathology Artificial Intelligence Guidance Engine (Paige AI). When Paige AI was used, diagnostic errors reduced by 70%.